Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo

Table 2

The association of serum IL-17A levels with clinical characteristics of vitiligo patients.

Clinical characteristics	N	Serum IL-17 level (pg/mL)	value
Gender
Females	34	3.12 (2.16–15.03)	0.81
Males	18	2.78 (2.11–10.08)
Ages
≤30 years	21	10.68 (3.09–32.91)	0.003
>30 years	31	2.78 (1.96–5.34)
Vitiligo activity
Stable	17	2.26 (1.94–6.32)	0.013
Progressive	35	4.35 (2.78–32.26)
Family history of vitiligo
Yes	11	2.26 (1.96–49.10)	0.69
No	41	3.09 (2.47–11.86)
Leukotrichia
Yes	14	8.27 (2.78–122.62)	0.04
No	38	2.99 (2.02–10.38)
Affected body surface area
<3%	32	3.08 (2.24–12.02)	0.82
3–10%	13	4.35 (2.42–11.86)
>10%	7	2.78 (1.78–16.

values were obtained by the Mann–Whitney U test. Data were shown as median (25th–75th).